Advertisement
Product › Details
EBiSC (European Bank for induced pluripotent Stem Cells)
Next higher product group | stem cell bank | |
Status | 2014-02-10 sales | |
Organisation | EBiSC project (European Bank for induced pluripotent Stem Cells) (IMI, EU, EFPIA 201402–) | |
Group | Innovative Health Initiative (IHI JU) | |
Record changed: 2023-07-10 |
Advertisement
More documents for cell therapy
- [1] Alia Therapeutics S.r.l.. (5/9/23). "Press Release: Alia Therapeutics Appoints Adel Nada as Independent Board Director". Milan....
- [2] Sarcura GmbH. (11/17/22). "Press Release: Sarcura Secures € 7M Seed Plus Funding to Revolutionize Cell Therapy Manufacturing". Klosterneuburg....
- [3] TreeFrog Therapeutics SAS. (6/10/22). "Press Release: Umoja Biopharma and TreeFrog Therapeutics Announce Collaboration to Address Current Challenges Facing ex vivo Allogeneic Therapies in Immuno-oncology". Seattle, WA & Pessac....
- [4] Bone Therapeutics S.A.. (5/12/22). "Press Release: Bone Therapeutics Enters into Exclusive Reverse Merger Discussions with Medsenic". Mont-Saint-Guibert....
- [5] TreeFrog Therapeutics SAS. (4/14/22). "Press Release: TreeFrog Therapeutics Expands Board with New Independent Members from the Cell Therapy Industry". Bordeaux....
- [6] TreeFrog Therapeutics SAS. (4/8/22). "Press Release: TreeFrog Therapeutics Opens Technological Hub in Kobe, Japan, to Drive Partnerships Opportunities in the Field of iPSC-derived Cell Therapies". Kobe....
- [7] XNK Therapeutics AB. (3/29/22). "Press Release: XNK Therapeutics Raises SEK 132 Million to Accelerate Growth"....
- [8] MedXCell S.A.. (3/11/22). "Press Release: MedXCell SA Is Proud to Annonce the Arrival of Andrew Galzaka and John D. McMannis as New Members of the Board and Pierre J.Magistretti as New Scientific Advisor". Montreux....
- [9] Cell-Easy. (2/28/22). "Press Release: The OPTI-STEM Consortium Led by CDMO Cell-Easy Receives €7M from the French Government and Bpifrance and €800,000 from the Occitanie Region to Democratize Access to Cell Therapy in France and Europe". Toulouse, La...
- [10] Quell Therapeutics Ltd.. (11/29/21). "Press Release: Quell Therapeutics Raises $156 Million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform". London & Boston,...
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top